Wikipedia / open kennis

Etavopivat

Etavopivat is an investigational new drug that is being evaluated by FORMA Therapeutics for the treatment of sickle cell disease and thalassemia. It is an…

Etavopivat is an investigational new drug that is being evaluated by FORMA Therapeutics for the treatment of sickle cell disease and thalassemia. It is an allosteric activator of the erythrocyte pyruvate kinase R (PKR) enzyme.

Clinical trials Etavopivat is in phase 3 clinical trials for sickle cell disease and thalassemia.

References

Bron en licentie

Gebaseerd op: Wikipedia — Etavopivat · auteursgeschiedenis.

Tekst: CC BY-SA 4.0.

Over de bewerking

Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.